Editorials Antibiotic drug research and development BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2591 (Published 11 April 2012) Cite this as: BMJ 2012;344:e2591 Article Related content Metrics Responses Peer review Related articles Analysis Challenges of drug resistance in the developing world Published: 03 April 2012; BMJ 344 doi:10.1136/bmj.e1567 Analysis 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards Published: 03 April 2012; BMJ 344 doi:10.1136/bmj.e1782 Editor's Choice Back to basics with the three Rs Published: 12 April 2012; BMJ 344 doi:10.1136/bmj.e2654 Letter Existing classes of antibiotics are probably the best we will ever have Published: 15 May 2012; BMJ 344 doi:10.1136/bmj.e3369 AnalysisChallenges of drug resistance in the developing worldAnalysis3Rs for innovating novel antibiotics: sharing resources, risks, and rewards See more Acute hepatitis is identified in more children, but cause remains elusive BMJ May 06, 2022, 377 o1156; DOI: https://doi.org/10.1136/bmj.o1156 French research institute faces criminal charges over “serious breaches” BMJ May 04, 2022, 377 o1117; DOI: https://doi.org/10.1136/bmj.o1117 Covid-19: China installs fences and alarms in Shanghai in effort to curb cases BMJ April 27, 2022, 377 o1076; DOI: https://doi.org/10.1136/bmj.o1076 Meningitis vaccine could protect against gonorrhoea, studies find BMJ April 19, 2022, 377 o997; DOI: https://doi.org/10.1136/bmj.o997 Covid-19: Health leaders accuse government of ignoring crisis in NHS BMJ April 14, 2022, 377 o981; DOI: https://doi.org/10.1136/bmj.o981 Cited by... Existing classes of antibiotics are probably the best we will ever haveFulltext PDF
